Skip to main content
Erschienen in: Sleep and Breathing 3/2019

14.11.2018 | Sleep Breathing Physiology and Disorders • Short Communication

Successful upper airway stimulation therapy in an adult Down syndrome patient with severe obstructive sleep apnea

verfasst von: Eli Van de Perck, Jolien Beyers, Marijke Dieltjens, Sara Op de Beeck, Johan Verbraecken, Paul Van de Heyning, An Boudewyns, Olivier M. Vanderveken

Erschienen in: Sleep and Breathing | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to report on the successful application of upper airway stimulation (UAS) therapy in an adult Down syndrome (DS) patient with severe obstructive sleep apnea (OSA) and continuous positive airway pressure (CPAP) intolerance.

Methods

Baseline polysomnography (PSG) in a 23-year-old male OSA patient (body mass index (BMI) 24.4 kg/m2) revealed an apnea/hypopnea index (AHI) of 61.5 events/h and oxygen desaturation index (ODI) of 39.7 events/h. Based on the clinical examination, PSG and drug-induced sleep endoscopy, the patient fulfilled the formal inclusion criteria for UAS therapy: AHI between 15 and 65 events/h, BMI < 32 kg/m2, and no complete concentric collapse at the level of the velopharynx.

Results

Implantation of the hypoglossal nerve stimulator in the adult patient with DS resulted in a substantial subjective as well as objective improvement of OSA (63 to 81% decrease in AHI and 77% decrease in ODI), translating into an overall satisfactory outcome.

Conclusion

Research on the long-term effectiveness of UAS therapy in a larger group of patients with DS is needed. However, based on the available literature and our presented case, respiration-synchronized electrostimulation of the hypoglossal nerve using UAS therapy may have a potential value in well-selected OSA patients with DS who are non-compliant to CPAP therapy.
Literatur
1.
Zurück zum Zitat Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A, N National Birth Defects Prevention (2010) Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88(12):1008–1016. https://doi.org/10.1002/bdra.20735 CrossRefPubMed Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A, N National Birth Defects Prevention (2010) Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88(12):1008–1016. https://​doi.​org/​10.​1002/​bdra.​20735 CrossRefPubMed
3.
Zurück zum Zitat Trois MS, Capone GT, Lutz JA, Melendres MC, Schwartz AR, Collop NA, Marcus CL (2009) Obstructive sleep apnea in adults with Down syndrome. J Clin Sleep Med 5(4):317–323PubMedPubMedCentral Trois MS, Capone GT, Lutz JA, Melendres MC, Schwartz AR, Collop NA, Marcus CL (2009) Obstructive sleep apnea in adults with Down syndrome. J Clin Sleep Med 5(4):317–323PubMedPubMedCentral
6.
Zurück zum Zitat Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD, M Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5(3):263–276 Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD, M Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5(3):263–276
7.
Zurück zum Zitat Yoshida K (1999) Elastic retracted oral appliance to treat sleep apnea in mentally impaired patients and patients with neuromuscular disabilities. J Prosthet Dent 81(2):196–201CrossRefPubMed Yoshida K (1999) Elastic retracted oral appliance to treat sleep apnea in mentally impaired patients and patients with neuromuscular disabilities. J Prosthet Dent 81(2):196–201CrossRefPubMed
8.
Zurück zum Zitat Strollo PJ Jr, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, Hanson RD, Padhya TA, Steward DL, Gillespie MB, Woodson BT, Van de Heyning PH, Goetting MG, Vanderveken OM, Feldman N, Knaack L, Strohl KP, ST Group (2014) Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 370(2):139–149. https://doi.org/10.1056/NEJMoa1308659 CrossRefPubMed Strollo PJ Jr, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, Hanson RD, Padhya TA, Steward DL, Gillespie MB, Woodson BT, Van de Heyning PH, Goetting MG, Vanderveken OM, Feldman N, Knaack L, Strohl KP, ST Group (2014) Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 370(2):139–149. https://​doi.​org/​10.​1056/​NEJMoa1308659 CrossRefPubMed
10.
Zurück zum Zitat Van de Heyning PH, Badr MS, Baskin JZ, Cramer Bornemann MA, De Backer WA, Dotan Y, Hohenhorst W, Knaack L, Lin HS, Maurer JT, Netzer A, Odland RM, Oliven A, Strohl KP, Vanderveken OM, Verbraecken J, Woodson BT (2012) Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope 122(7):1626–1633. https://doi.org/10.1002/lary.23301 CrossRefPubMed Van de Heyning PH, Badr MS, Baskin JZ, Cramer Bornemann MA, De Backer WA, Dotan Y, Hohenhorst W, Knaack L, Lin HS, Maurer JT, Netzer A, Odland RM, Oliven A, Strohl KP, Vanderveken OM, Verbraecken J, Woodson BT (2012) Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope 122(7):1626–1633. https://​doi.​org/​10.​1002/​lary.​23301 CrossRefPubMed
12.
Zurück zum Zitat Diercks GR, Wentland C, Keamy D, Kinane TB, Skotko B, de Guzman V, Grealish E, Dobrowski J, Soose R, Hartnick CJ (2017) Hypoglossal nerve stimulation in adolescents with Down syndrome and obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg. https://doi.org/10.1001/jamaoto.2017.1871 Diercks GR, Wentland C, Keamy D, Kinane TB, Skotko B, de Guzman V, Grealish E, Dobrowski J, Soose R, Hartnick CJ (2017) Hypoglossal nerve stimulation in adolescents with Down syndrome and obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg. https://​doi.​org/​10.​1001/​jamaoto.​2017.​1871
15.
Zurück zum Zitat Beyers J, Dieltjens M, Kastoer C, Opdebeeck L, Boudewyns AN, De Volder I, Van Gastel A, Verbraecken JA, De Backer WA, Braem MJ, Van de Heyning PH, Vanderveken OM (2018) Evaluation of a trial period with a sleep position trainer in patients with positional sleep apnea. J Clin Sleep Med 14:575–583CrossRefPubMedPubMedCentral Beyers J, Dieltjens M, Kastoer C, Opdebeeck L, Boudewyns AN, De Volder I, Van Gastel A, Verbraecken JA, De Backer WA, Braem MJ, Van de Heyning PH, Vanderveken OM (2018) Evaluation of a trial period with a sleep position trainer in patients with positional sleep apnea. J Clin Sleep Med 14:575–583CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat De Vito A, Carrasco Llatas M, Vanni A, Bosi M, Braghiroli A, Campanini A, de Vries N, Hamans E, Hohenhorst W, Kotecha BT, Maurer J, Montevecchi F, Piccin O, Sorrenti G, Vanderveken OM, Vicini C (2014) European position paper on drug-induced sedation endoscopy (DISE). Sleep Breath 18(3):453–465. https://doi.org/10.1007/s11325-014-0989-6 CrossRefPubMed De Vito A, Carrasco Llatas M, Vanni A, Bosi M, Braghiroli A, Campanini A, de Vries N, Hamans E, Hohenhorst W, Kotecha BT, Maurer J, Montevecchi F, Piccin O, Sorrenti G, Vanderveken OM, Vicini C (2014) European position paper on drug-induced sedation endoscopy (DISE). Sleep Breath 18(3):453–465. https://​doi.​org/​10.​1007/​s11325-014-0989-6 CrossRefPubMed
21.
Zurück zum Zitat Woodson BT, Strohl KP, Soose RJ, Gillespie MB, Maurer JT, de Vries N, Padhya TA, Badr MS, Lin HS, Vanderveken OM, Mickelson S, Strollo PJ Jr (2018) Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Head Neck Surg 194599818762383:194–202. https://doi.org/10.1177/0194599818762383 CrossRef Woodson BT, Strohl KP, Soose RJ, Gillespie MB, Maurer JT, de Vries N, Padhya TA, Badr MS, Lin HS, Vanderveken OM, Mickelson S, Strollo PJ Jr (2018) Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Head Neck Surg 194599818762383:194–202. https://​doi.​org/​10.​1177/​0194599818762383​ CrossRef
23.
Zurück zum Zitat Beyers J, Dieltjens M, Vonk PE, Ravesloot MJ, Willemen M, Verbraecken JA, Van de Heyning PH, de Vries N, Vanderveken OM (2018) Prevalence and clinical significance of positional obstructive sleep apnea in patients treated with upper airway stimulation therapy. Sleep Breath. abstract International Sleep Surgery Society Meeting, Munich, Germany, April 5-7, 2018 Beyers J, Dieltjens M, Vonk PE, Ravesloot MJ, Willemen M, Verbraecken JA, Van de Heyning PH, de Vries N, Vanderveken OM (2018) Prevalence and clinical significance of positional obstructive sleep apnea in patients treated with upper airway stimulation therapy. Sleep Breath. abstract International Sleep Surgery Society Meeting, Munich, Germany, April 5-7, 2018
Metadaten
Titel
Successful upper airway stimulation therapy in an adult Down syndrome patient with severe obstructive sleep apnea
verfasst von
Eli Van de Perck
Jolien Beyers
Marijke Dieltjens
Sara Op de Beeck
Johan Verbraecken
Paul Van de Heyning
An Boudewyns
Olivier M. Vanderveken
Publikationsdatum
14.11.2018
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 3/2019
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-018-1752-1

Weitere Artikel der Ausgabe 3/2019

Sleep and Breathing 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.